Fundz

Laxai Receives Investment From Signet Healthcare Partners

PRIVATEOct 24, 2022

Round Type

Venture

ManufacturingBiotechnologyPharmaceutical

Description

LAXAI Inc. (“LAXAI”) announced today that it has received a growth capital investment from SIGNET Healthcare Partners (“SIGNET”), a New York-based healthcare private equity firm. This significant equity investment from SIGNET aims to provide LAXAI with a long-term, well-capitalized financial partner that will support LAXAI’s growth strategy.

Quick answer

LAXAI raised an undisclosed amount in a funding round, dated October 24, 2022.

How much did LAXAI raise?
LAXAI raised an undisclosed amount in a funding round on October 24, 2022.
What does LAXAI do?
LAXAI offers contract research, development, and manufacturing solutions to pharmaceutical and specialty chemical companies globally.

Source: Fundz verified event record.

Who else raised in Pharmaceutical and Manufacturing around the same time

Companies in the same sectors as LAXAI that raised within 45 days of this round, from Fundz verified event records.

  • Alvotech raised an undisclosed amount (Funding Round) on November 16, 2022.
  • Fennec Pharmaceuticals raised $20M on September 26, 2022.
  • CASI Pharmaceuticals raised an undisclosed amount on September 23, 2022.
  • Meta Materials raised an undisclosed amount (Series A) on December 7, 2022.
  • ExPLoRNA Therapeutics raised an undisclosed amount (Funding Round) on December 7, 2022.
  • Trillium Renewable Chemicals raised $11M (Series A) on December 6, 2022.

Who to call at LAXAI, and when

A new round usually means LAXAI is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day LAXAI raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at LAXAI, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at LAXAI. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

LAXAI

About

LAXAI offers contract research, development, and manufacturing solutions to pharmaceutical and specialty chemical companies globally. For more than a decade, LAXAI has collaborated with pharmaceutical companies across the value chain and partnered on multiple medicinal chemistry, integrated drug discovery, CMC Programs, and scale-up of custom-made specialty fine chemicals. For more information, visit www.laxai.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment LAXAI raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for LAXAI's next move

See what Strategic adds

LAXAI raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.